Your browser doesn't support javascript.
loading
Proteomics of Human Dendritic Cell Subsets Reveals Subset-Specific Surface Markers and Differential Inflammasome Function.
Worah, Kuntal; Mathan, Till S M; Vu Manh, Thien Phong; Keerthikumar, Shivakumar; Schreibelt, Gerty; Tel, Jurjen; Duiveman-de Boer, Tjitske; Sköld, Annette E; van Spriel, Annemiek B; de Vries, I Jolanda M; Huynen, Martijn A; Wessels, Hans J; Gloerich, Jolein; Dalod, Marc; Lasonder, Edwin; Figdor, Carl G; Buschow, Sonja I.
Afiliação
  • Worah K; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands.
  • Mathan TSM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands.
  • Vu Manh TP; Centre d'Immunologie, de Marseille-Luminy, Aix Marseille University UM2, Inserm, U1104, CNRS UMR7280, Cedex 09, 13288 Marseille, France.
  • Keerthikumar S; Centre for Molecular and Biomolecular Informatics (CMBI), Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands.
  • Schreibelt G; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands.
  • Tel J; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands.
  • Duiveman-de Boer T; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands.
  • Sköld AE; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands; Department of Oncology-Pathology, Karolinska University Hospital Solna, Karolinska Institutet, 171 76 Stockholm, Sweden.
  • van Spriel AB; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands.
  • de Vries IJM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands; Department of Medical Oncology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB
  • Huynen MA; Centre for Molecular and Biomolecular Informatics (CMBI), Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands.
  • Wessels HJ; Radboud Proteomics Centre, Department of Laboratory Medicine, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands; Nijmegen Centre for Mitochondrial Disorders, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands.
  • Gloerich J; Radboud Proteomics Centre, Department of Laboratory Medicine, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands.
  • Dalod M; Centre d'Immunologie, de Marseille-Luminy, Aix Marseille University UM2, Inserm, U1104, CNRS UMR7280, Cedex 09, 13288 Marseille, France.
  • Lasonder E; Centre for Molecular and Biomolecular Informatics (CMBI), Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands; School of Biomedical and Healthcare Sciences, B427 Portland Square, Plymouth University, Drake Circus, Plymouth, Devon PL4 8AA, UK.
  • Figdor CG; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands. Electronic address: carl.figdor@radboudumc.nl.
  • Buschow SI; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands; Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, 3015 CN Rotterdam, the Netherlands. Electronic addr
Cell Rep ; 16(11): 2953-2966, 2016 09 13.
Article em En | MEDLINE | ID: mdl-27626665
ABSTRACT
Dendritic cells (DCs) play a key role in orchestrating adaptive immune responses. In human blood, three distinct subsets exist plasmacytoid DCs (pDCs) and BDCA3+ and CD1c+ myeloid DCs. In addition, a DC-like CD16+ monocyte has been reported. Although RNA-expression profiles have been previously compared, protein expression data may provide a different picture. Here, we exploited label-free quantitative mass spectrometry to compare and identify differences in primary human DC subset proteins. Moreover, we integrated these proteomic data with existing mRNA data to derive robust cell-specific expression signatures with more than 400 differentially expressed proteins between subsets, forming a solid basis for investigation of subset-specific functions. We illustrated this by extracting subset identification markers and by demonstrating that pDCs lack caspase-1 and only express low levels of other inflammasome-related proteins. In accordance, pDCs were incapable of interleukin (IL)-1ß secretion in response to ATP.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Dendríticas / Biomarcadores / Proteômica / Inflamassomos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cell Rep Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Dendríticas / Biomarcadores / Proteômica / Inflamassomos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cell Rep Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Holanda